Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Pemigatinib for locally advanced or metastatic, relapsed or refractory cholangiocarcinoma with FGFR2 fusion or rearrangement Pemigatinib (INCB054828) Cholangiocarcinoma Gastrointestinal Cancer 2019 View  |  Download
Pemigatinib for treating myeloproliferative neoplasms with FGFR1 rearrangement Pemigatinib (INCB054828) Myeloproliferative Neoplasms Haematological Cancer and Lymphomas 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications